Autophagic dysregulation in doxorubicin cardiomyopathy. (Q39096944)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28108310%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

title

Autophagic dysregulation in doxorubicin cardiomyopathy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28108310%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

0 references

0 references

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28108310%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

author name string

Jordan J Bartlett

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28108310%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

Purvi C Trivedi

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28108310%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

publication date

17 January 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28108310%20AND%20SRC:MED&resulttype=core&format=json

Journal of Molecular and Cellular Cardiology

9 April 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28108310%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

volume

104

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28108310%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

page(s)

1-8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28108310%20AND%20SRC:MED&resulttype=core&format=json

At the end of the autophagic road: an emerging understanding of lysosomal functions in autophagy.

9 April 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2017.01.007

Pathways of cardiac toxicity: comparison between chemotherapeutic drugs doxorubicin and mitoxantrone.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2017.01.007

Cardiomyocyte autophagy and cancer chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2017.01.007

Doxorubicin cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2017.01.007

Doxorubicin induced heart failure: Phenotype and molecular mechanisms.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2017.01.007

Daunorubicin-DNA and doxorubicin-DNA a review of experimental and clinical data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2017.01.007

Sirtuin-3 (SIRT3) Protein Attenuates Doxorubicin-induced Oxidative Stress and Improves Mitochondrial Respiration in H9c2 Cardiomyocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2017.01.007

Mitochondrial Targeting of Doxorubicin Eliminates Nuclear Effects Associated with Cardiotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2017.01.007

Two distinct modes of cell death induced by doxorubicin: apoptosis and cell death through mitotic catastrophe accompanied by senescence-like phenotype

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2017.01.007

Identification of the molecular basis of doxorubicin-induced cardiotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2017.01.007

Doxorubicin acts via mitochondrial ROS to stimulate catabolism in C2C12 myotubes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2017.01.007

Doxorubicin induces protein ubiquitination and inhibits proteasome activity during cardiotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2017.01.007

Adriamycin-induced interference with cardiac mitochondrial calcium homeostasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2017.01.007

Persistent alterations to the gene expression profile of the heart subsequent to chronic Doxorubicin treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2017.01.007

Antioxidants and cancer therapy: a systematic review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2017.01.007

Cardioprotective interventions for cancer patients receiving anthracyclines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2017.01.007

Cardiomyocyte specific adipose triglyceride lipase overexpression prevents doxorubicin induced cardiac dysfunction in female mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2017.01.007

ATP-induced autophagy is associated with rapid killing of intracellular mycobacteria within human monocytes/macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2017.01.007

Akt activates the mammalian target of rapamycin by regulating cellular ATP level and AMPK activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2017.01.007

Berberine inhibits doxorubicin-triggered cardiomyocyte apoptosis via attenuating mitochondrial dysfunction and increasing Bcl-2 expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2017.01.007

Nrf2 deficiency exaggerates doxorubicin-induced cardiotoxicity and cardiac dysfunction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2017.01.007

Doxorubicin impairs cardiomyocyte viability by suppressing transcription factor EB expression and disrupting autophagy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2017.01.007

Doxorubicin Blocks Cardiomyocyte Autophagic Flux by Inhibiting Lysosome Acidification.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2017.01.007

Doxorubicin Regulates Autophagy Signals via Accumulation of Cytosolic Ca2+ in Human Cardiac Progenitor Cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2017.01.007

Aldehyde dehydrogenase 2 ameliorates doxorubicin-induced myocardial dysfunction through detoxification of 4-HNE and suppression of autophagy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2017.01.007

Elimination of damaged mitochondria through mitophagy reduces mitochondrial oxidative stress and increases tolerance to trichothecenes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2017.01.007

Mitochondria and mitophagy: the yin and yang of cell death control

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2017.01.007

Doxorubicin alters the mitochondrial dynamics machinery and mitophagy in the liver of treated animals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2017.01.007

Attenuation of doxorubicin-induced cardiotoxicity by mdivi-1: a mitochondrial division/mitophagy inhibitor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2017.01.007

A time to reap, a time to sow: mitophagy and biogenesis in cardiac pathophysiology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2017.01.007

Cardiomyocyte mitochondrial oxidative stress and cytoskeletal breakdown in the heart with a primary volume overload

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2017.01.007

DNA damage induces reactive oxygen species generation through the H2AX-Nox1/Rac1 pathway.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2017.01.007

Mitochondrial dysfunction in heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2017.01.007

Cytosolic p53 inhibits Parkin-mediated mitophagy and promotes mitochondrial dysfunction in the mouse heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2017.01.007

Autophagy upregulation promotes survival and attenuates doxorubicin-induced cardiotoxicity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2017.01.007

Autophagy prevents doxorubicin‑induced apoptosis in osteosarcoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2017.01.007

Transcription factor GATA4 inhibits doxorubicin-induced autophagy and cardiomyocyte death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2017.01.007

Regulation of the transcription factor EB-PGC1α axis by beclin-1 controls mitochondrial quality and cardiomyocyte death under stress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2017.01.007

TLR4 activation under lipotoxic conditions leads to synergistic macrophage cell death through a TRIF-dependent pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2017.01.007

Early cellular changes after blockage of chaperone-mediated autophagy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2017.01.007

AMPK-dependent phosphorylation of ULK1 induces autophagy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2017.01.007

Prior starvation mitigates acute doxorubicin cardiotoxicity through restoration of autophagy in affected cardiomyocytes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2017.01.007

Selective autophagy mediated by autophagic adapter proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2017.01.007

The interplay between autophagy and apoptosis in the diabetic heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2017.01.007

Autophagosomes form at ER-mitochondria contact sites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2017.01.007

ULK1 induces autophagy by phosphorylating Beclin-1 and activating VPS34 lipid kinase.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2017.01.007

Lipidation of the LC3/GABARAP family of autophagy proteins relies on a membrane-curvature-sensing domain in Atg3.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2017.01.007

p62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2017.01.007

Proteotoxic stress induces phosphorylation of p62/SQSTM1 by ULK1 to regulate selective autophagic clearance of protein aggregates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2017.01.007

Activation of lysosomal function in the course of autophagy via mTORC1 suppression and autophagosome-lysosome fusion.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2017.01.007

The role of PI3K/AKT/mTOR pathway in the modulation of autophagy and the clearance of protein aggregates in neurodegeneration.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2017.01.007

Metabolism. AMP-activated protein kinase mediates mitochondrial fission in response to energy stress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2017.01.007

Regulation of autophagy by coordinated action of mTORC1 and protein phosphatase 2A.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2017.01.007

Ghrelin inhibits doxorubicin cardiotoxicity by inhibiting excessive autophagy through AMPK and p38-MAPK.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2017.01.007

Resveratrol attenuates doxorubicin-induced cardiomyocyte death via inhibition of p70 S6 kinase 1-mediated autophagy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2017.01.007

Adriamycin-induced autophagic cardiomyocyte death plays a pathogenic role in a rat model of heart failure.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2017.01.007

Acetaminophen attenuates doxorubicin-induced cardiac fibrosis via osteopontin and GATA4 regulation: reduction of oxidant levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2017.01.007

Bcl-2 prevents doxorubicin-induced apoptosis of human liver cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2017.01.007

Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2017.01.007

LAMP-2: a control step for phagosome and autophagosome maturation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2017.01.007

Macrophage migration inhibitory factor deficiency augments doxorubicin-induced cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2017.01.007

Basal autophagy protects cardiomyocytes from doxorubicin-induced toxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2017.01.007

Proteotoxicity and cardiac dysfunction--Alzheimer's disease of the heart?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2017.01.007

Lipophagy: connecting autophagy and lipid metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2017.01.007

Autophagy in the cellular energetic balance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2017.01.007

Chaperone-mediated autophagy: machinery, regulation and biological consequences

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2017.01.007

Chaperone-mediated autophagy: molecular mechanisms and physiological relevance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2017.01.007

Selective Degradation of Annexins by Chaperone-mediated Autophagy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2017.01.007

Peptide sequences that target cytosolic proteins for lysosomal proteolysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2017.01.007

Chaperone-mediated autophagy in health and disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2017.01.007

Activation of a selective pathway of lysosomal proteolysis in rat liver by prolonged starvation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2017.01.007

Chaperone-mediated autophagy: a unique way to enter the lysosome world

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2017.01.007

A receptor for the selective uptake and degradation of proteins by lysosomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2017.01.007

Proteomic insights into chronic anthracycline cardiotoxicity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2017.01.007

Exercise protects against doxorubicin-induced markers of autophagy signaling in skeletal muscle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2017.01.007

Doxorubicin-induced cell death requires cathepsin B in HeLa cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2017.01.007

TFEB regulates autophagy: An integrated coordination of cellular degradation and recycling processes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2017.01.007

TFEB links autophagy to lysosomal biogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2017.01.007

Erratum: TFEB controls cellular lipid metabolism through a starvation-induced autoregulatory loop

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2017.01.007

A lysosome-to-nucleus signalling mechanism senses and regulates the lysosome via mTOR and TFEB

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2017.01.007

A gene network regulating lysosomal biogenesis and function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2017.01.007

The transcription factor TFEB links mTORC1 signaling to transcriptional control of lysosome homeostasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2017.01.007

TFEB regulates lysosomal proteostasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2017.01.007

Repetitive stimulation of autophagy-lysosome machinery by intermittent fasting preconditions the myocardium to ischemia-reperfusion injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2017.01.007

Deficient chaperone-mediated autophagy in liver leads to metabolic dysregulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2017.01.007

Role of autophagy in heart failure associated with aging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2017.01.007

Natural history of Danon disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2017.01.007

Chaperone-mediated autophagy prevents apoptosis by degrading BBC3/PUMA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2017.01.007

10.1016/J.YJMCC.2017.01.007

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28108310%20AND%20SRC:MED&resulttype=core&format=json

release_h7fqeqkb2jguxm5xkxpme674gy

9 April 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/h7fqeqkb2jguxm5xkxpme674gy

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference